Clinical Trial

Levodopa for Diabetic Retinopathy

Name: Levodopa for Diabetic Retinopathy — clinical trial record (NCT07444892)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 2

View on ClinicalTrials.gov →

Summary

The purpose of this study is to determine optimum dosing strategies of levodopa and determine the physiologic mechanisms that provide the therapeutic response to restore abnormalities in the electrical conductivity of the retina in people with diabetes and no clinically visible retinopathy.

Trial Details

NCT Number	NCT07444892
Lead Sponsor	Emory University Collaborators: Morningside Center for Innovative and Affordable Medicine
Conditions	Diabetic Retinopathy
Enrollment	230 participants
Start Date	2022-04-18
Primary Completion	2025-11-17 (estimated)
Study Completion	2025-11-17 (estimated)
Updated on ClinicalTrials.gov	2026-03-03